ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Genentech, AbbVie Add To Drug Plants

by Rick Mullin
April 6, 2015 | APPEARED IN VOLUME 93, ISSUE 14

Genentech will invest $125 million to expand its pharmaceutical fill-and-finish facility in Hillsboro, Ore. The company plans to add 100 skilled manufacturing jobs at the site, which includes a warehousing and distribution center, over the next five years. This would bring the total number of Genentech employees in the state to more than 500. AbbVie, meanwhile, will spend $30 million to expand a plant in Barceloneta, P.R., a city where it makes both small-molecule and biologic drug active ingredients.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment